O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Jenscare Scientific’s Hong Kong IPO
O’Melveny Grows New York Corporate Practice with Media and Technology Trailblazer Matthew Syrkin
O’Melveny announced that acclaimed transactional lawyer Matthew Syrkin has joined the firm as a partner in New York. Syrkin will serve as co-chair of O’Melveny’s MediaTech...
Solid State’s Acquisition of Custom Power
O’Melveny advised Custom Power on the deal. Custom Power, LLC, a leader in engineering and manufacturing highly customized, mission-critical power solutions, announced its sale from investment firm...
Youdao Development International’s US$83 Million Shares Acquisition in CCRE
O’Melveny recently represented Central China Real Estate Limited and its controlling shareholder, Joy Bright Investments Limited, on the deal. Central China Real Estate Limited (CCRE) (0832.HK)...
Heritage-Crystal Clean’s Acquisition of Patriot Environmental Services
O’Melveny & Myers LLP advised Solace Capital Partners, L.P. and Patriot Environmental Services, Inc. on the deal. Solace Capital Partners, L.P. and Patriot Environmental Services, Inc.,...
Genesis Growth Tech Acquisition Corp.’s Merger with Biolog-ID
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Charles Russell Speechlys and Carey Olsen served as legal counsel to Biolog-id. O’Melveny & Myers LLP, Allen &...
C&D International’s US$64 Million Top-up Share Placement and Subscription
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited (CICC) and China Industrial Securities International Capital Limited on the deal. China International Capital Corporation Hong...
Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
Source Capital’s Investment in Amplifi Group
O’Melveny represented Amplifi Group on the deal. Amplifi Group, a leading strategy and information management consultancy, announced a strategic growth investment it received from Source Capital,...
Lushang Life Services Co., Ltd.’s HK$138.4 Million Hong Kong IPO
Sidley represented Lushang Life Services Co., Ltd. on the deal while O’Melveny advised ABCI Capital Limited and China International Capital Corporation Hong Kong Securities Limited. Lushang...
Epsilon3’s US$15 Million Series A Funding
O’Melveny & Myers LLP advised Epsilon3 on the deal. Epsilon3, a web-based platform for managing complex operations, announced its US$15 million Series A funding round. The...
SK Innovation’s Investment in Amogy
O’Melveny advised SK Innovation on the deal while Wilson Sonsini represented Amogy. SK Innovation announced its investment in Amogy Inc., a pioneer of ammonia power solutions. The...